Acadia Healthcare Company, Inc. 8-K

What Happened
Acadia Healthcare Company, Inc. (ACHC) filed a Form 8-K on January 13, 2026 saying company representatives will present at the 44th Annual J.P. Morgan Healthcare Conference with a live webcast at 5:15 p.m. PT / 7:15 p.m. CT on January 13, 2026. During the presentation Acadia reaffirmed its previously issued 2025 financial guidance (from Nov. 5, 2025, as updated Dec. 2, 2025). The company furnished slides for the presentation as Exhibit 99 to the 8-K.

Key Details

• Reaffirmed 2025 guidance: Revenue $3.28 billion to $3.30 billion.
• Reaffirmed 2025 adjusted EBITDA: $601 million to $611 million.
• Reaffirmed 2025 adjusted earnings per share: $1.94 to $2.04.
• Presentation webcast available on Acadia’s investor site (replay posted for 30 days); slides dated January 13, 2026 were furnished with the filing.

Why It Matters
Reaffirming full-year 2025 guidance gives investors a clear, current set of targets for revenue, profitability (adjusted EBITDA), and adjusted EPS that analysts and models will use when evaluating Acadia’s near-term performance. The J.P. Morgan presentation and slides provide management commentary and context that can influence expectations, so the webcast/replay is a direct way for investors to hear management’s views on operating trends and outlook.